The banking sector is currently going through a challenging phase, marked by rising interest rates and tariff-related headwinds. When Bank of America (BAC) reports its third-quarter results on Monday before the opening bell, the market will be looking for earnings of $0.62 per share. Revenues are estimated to rise 2.7% year-on-year to $22.67 billion during the three-month period.
The long-term trend of positive earnings performance is expected to continue in the third quarter, with a higher probability of beating the forecast. The management’s cost-reduction program will have a favorable impact on profitability, offsetting the pressure from higher interest rates. The rebound of trading revenue this year, after last year’s muted performance, is another positive factor.
The management’s cost-reduction program will have a favorable impact on profitability, offsetting the pressure from higher interest rates
Bank of America being a leading mortgage lender, the post-earnings discussion of its top executives is likely to touch upon the challenges facing the housing market and the revised monetary policy of the Federal Reserve, which is currently preparing for this year’s fourth rate hike in December.
Usually, back-to-back rate hikes leave banks in a tricky situation, wherein the initial befits from higher rates tend to reverse in the long term, owing to diminishing demand for loans and the increase in the interest payable to deposit holders.
In the second quarter, the Charlotte, North Carolina-based financial services provider reported a 43% growth in earnings to $0.63 per share, despite a modest drop in revenues.
Kicking off this season’s financial earnings, JPMorgan Chase (JPM) Friday posted a 5.2% growth in third-quarter revenues, which pushed up earnings by 33% to $2.34 per share. Earnings of Citigroup [C] climbed 21% to $1.73 per share in the most recent quarter, helped mainly by lower corporate taxes.
Bank of America shares lost about 8% since the beginning of the year. After opening Friday’s regular session slightly higher, the stock traded lower throughout the day. The current spell of decline that started in mid-September is expected to continue in the coming weeks.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on